National Quality Forum, Washington, DC

National Quality Forum

www.qualityforum.org

The National Quality Forum (NQF) is the nation`s resource for healthcare quality measurement and improvement. NQF is an independent, not-for-profit, membership-based organization that brings healthcare stakeholders together to recommend quality measures and improvement strategies that reduce costs and help patients get better care. NQF`s membership consists of more than 400 organizations that represent physicians, nurses, hospitals, healthcare systems, patients, families, health plans, employers, and others committed to healthcare quality. Through its multistakeholder membership, NQF facilitates an open and thorough dialogue on healthcare measurement and improvement, and leads national collaboration to improve health and healthcare quality for all Americans.

Number of Employees: 25-100
Annual Revenue: $1-10 Million

www.qualityforum.org
1030 15th Street NW Suite 800
Washington, DC USA 20005
Phone: 202.783.1300

Similar Companies

Lincoln County Ambulance District

Lincoln County Ambulance District is a Troy, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

CTOs on the Move